Back to Search Start Over

VISTA deficiency protects from immune complex-mediated glomerulonephritis by inhibiting neutrophil activation.

Authors :
Tham EL
Freeley SJ
Bearder S
Barros FF
Cragg MS
Mócsai A
Robson MG
Source :
Journal of autoimmunity [J Autoimmun] 2020 Sep; Vol. 113, pp. 102501. Date of Electronic Publication: 2020 Jun 22.
Publication Year :
2020

Abstract

V-type immunoglobulin domain-containing suppressor of T-cell activation (VISTA) is a negative checkpoint regulator of T cells. We assessed VISTA deficient mice in the murine nephrotoxic nephritis models of acute and chronic immune-complex mediated glomerulonephritis. We show that VISTA deficiency protects from crescentic glomerulonephritis, with no effect on the nephritogenic adaptive immune response. The early neutrophil influx was unaffected but proteinuria was reduced suggesting a reduction in neutrophil activation. In vivo, there was reduced neutrophil degranulation in VISTA deficienct mice and, in vitro, VISTA-deficient neutrophils had an impaired response to immune complexes but not to fMLP or PMA. Mice with a genetic deficiency of neutrophils due to myeloid-specific deletion of myeloid cell leukemia 1 (Mcl-1) were also protected from crescentic glomerulonephritis, indicating an essential role for neutrophils. Therefore, VISTA deficiency inhibits neutrophil activation by immune complexes and neutrophil-dependent crescentic glomerulonephritis. This suggests that VISTA is a therapeutic target for inflammatory disease. However, this would need to be balanced against a potential enhancing effect on autoimmunity.<br /> (Copyright © 2020 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1095-9157
Volume :
113
Database :
MEDLINE
Journal :
Journal of autoimmunity
Publication Type :
Academic Journal
Accession number :
32586651
Full Text :
https://doi.org/10.1016/j.jaut.2020.102501